| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b6121dedd894b3f760906b68697d616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8affe9c6e402d138fb55ceb0d985d433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_971f98e8d552b2214808581892320247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c41fad0ea969e1e732c198b72c347192 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55588
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-523 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-00 |
| filingDate |
2008-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e22fa23583a87bc05be4aeec62428d5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a795bdebd36d4d9c51669ae92ceff8c7 |
| publicationDate |
2012-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8337830-B2 |
| titleOfInvention |
Yeast-based vaccines as immunotherapy |
| abstract |
Compositions and methods for treating and/or preventing a variety of diseases and conditions that are amenable to immunotherapy and, in one particular embodiment, compositions and methods for treating and/or preventing cancer in an animal are described. Specifically improvements related to the use of a yeast-based vaccine comprising a yeast vehicle and an antigen that is selected to elicit an antigen-specific cellular and humoral immune response in an animal, for use in prophylactic and/or therapeutic vaccination and the prevention and/or treatment of a variety of diseases and conditions are disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8877205-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9428556-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8722054-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8961988-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9333246-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10799567-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9290547-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9943591-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10441650-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017035867-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8734778-B2 |
| priorityDate |
2002-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |